Bladder cancer in the EMPA-REG OUTCOME trial
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
George, Jyothis T.
Inzucchi, Silvio E.
Funding for this research was provided by:
The EMPA-REG OUTCOME trial was funded by the Boehringer Ingelheim & Eli Lilly and Company Diabetes Alliance.
unspecified valid from 2017-09-14